Craig-Hallum analyst Matt Hewitt assigned a Buy rating to the stock today. The company’s shares closed last Wednesday at $6.13.Stay Ahead of ...
Maravai Lifesciences Holdings, Inc. (Maravai) has announced its preliminary unaudited 2024 revenue, expecting to report total ...